Oct 7, 2014, MIT News: Autism as a disorder of prediction
Oct 3, 2014, Examiner.com: First healthy volunteers injected with experimental GMO Ebola vaccine
Autism is characterized by many different symptoms: difficulty interacting with others, repetitive behaviors, and hypersensitivity to sound and other stimuli. MIT neuroscientists have put forth a new hypothesis that accounts for these behaviors and may provide a neurological foundation for many of the disparate features of the disorder.
The researchers suggest that autism may be rooted in an impaired ability to predict events and other people's actions. From the perspective of the autistic child, the world appears to be a "magical" rather than an orderly place, because events seem to occur randomly and unpredictably. In this view, autism symptoms such as repetitive behavior, and an insistence on a highly structured environment, are coping strategies to help deal with this unpredictable world.
I'm sick to death of this kind of wordplay. "The MIT team believes this could result from an inability to predict another person's behavior based on past interactions. People with autism have difficulty using this type of context, and tend to interpret behavior based only on what is happening in that very moment."
I posted a comment and reminded them of this MIT research....In June, 2014, MIT's Dr. Stephanie Seneff predicted that by 2025...that's eleven years from now...., the U.S. autism rate will be one in every two kids.
(I don't see my comment.)
Maybe the folks at MIT would like to see the kids with autism I work with. They definitely have "an inability to predict another person's behavior based on past interactions."
They're in diapers---and they're NOT BABIES. One girl is twenty. They're nonverbal. I don't know... if they can "predict another person's behavior based on past interactions."
Actually, my goal is get them to make eye contact with me and notice that I'm in the room.
Genetically modified Ebola vaccines are already being administered to healthy volunteers in the United States, UK, Gambia and Mali, as officials worldwide are fast-tracking the creation and approval of an Ebola vaccine.
Glaxo Smith Kline said in a press release:
The Oxford study will involve 60 healthy volunteers, while those in The Gambia and Mali will each involve 40. Each set of volunteers will be split into groups of 20 that will receive different doses of the vaccine so researchers can evaluate the best dose to use in terms of both safety and activity.
NIAID are testing this same vaccine in the USA, in addition to a related vaccine that is designed to protect against two Ebola species (Ebola Zaire and Ebola Sudan).
I'm sure this will be sold to us as DEATH IS JUST A PLANE RIDE AWAY. Where woulld we be without a worldwide pandemic every few years? And our only hope is a vaccine.
The Dachel Media Update is sponsored by Lee Silsby Compounding Pharmacy and their OurKidsASD brand. Lee Silsby Compounding Pharmacy is one of the largest and most respected compounding pharmacies in the country. They use only the finest quality chemicals and equipment to prepare our patients’ compounded medications and nutritional supplements. Customizing medication and nutritional supplements for our customers allows them to achieve their unique health goals.
Anne Dachel is Media Editor for Age of Autism and author of The Big Autism Cover-Up: How and Why the Media Is Lying to the American Public, which goes on sale this Fall from Skyhorse Publishing.